{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T05:41:10Z","timestamp":1779342070403,"version":"3.51.4"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1994,1,1]],"date-time":"1994-01-01T00:00:00Z","timestamp":757382400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Tr"],"published-print":{"date-parts":[[1994]]},"DOI":"10.1007\/bf00666177","type":"journal-article","created":{"date-parts":[[2004,11,27]],"date-time":"2004-11-27T08:35:48Z","timestamp":1101544548000},"page":"3-9","source":"Crossref","is-referenced-by-count":100,"title":["The type I growth factor receptors in human breast cancer"],"prefix":"10.1007","volume":"29","author":[{"given":"Thangarajan","family":"Rajkumar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William John","family":"Gullick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","first-page":"69","volume-title":"Cancer: Causes, Occurrence and Control","year":"1990","unstructured":"Tomatis L, Aitio A, Day NE, Heseltine E, Kaldor J, Miller AB, Parkin DM, Riboli E (eds) Cancer: Causes, Occurrence and Control. International Agency for Research on Cancer, Lyon, 1990, pp 69?71"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0955-2235(90)90006-6","volume":"2","author":"WJ Gullick","year":"1990","unstructured":"Gullick WJ: Growth factors and oncogenes in breast cancer. Prog Growth Factor Res 2:1?13, 1990","journal-title":"Prog Growth Factor Res"},{"key":"CR3","first-page":"33","volume":"1072","author":"MJ Vijver Van de","year":"1991","unstructured":"Van de Vijver MJ, Nusse R: The molecular biology of breast cancer. Biochem Biophys Acta 1072:33?50, 1991","journal-title":"Biochem Biophys Acta"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/bjc.1992.420","volume":"66","author":"NR Lemoine","year":"1992","unstructured":"Lemoine NR, Barnes DM, Hollywood DP, Hughes CM, Smith P, Dublin E, Prigent SA, Gullick WJ, Hurst HC: Expression of erbB3 gene product in breast cancer. Br J Cancer 66:1116?1112, 1992","journal-title":"Br J Cancer"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1073\/pnas.90.5.1746","volume":"90","author":"GD Plowman","year":"1993","unstructured":"Plowman GD, Culouscou JM, Whitney GS, Green JM, Carlton GW, Foy L, Neubauer MG, Shoyab M: Ligand specific activation of HER4\/p180erbB4, a fourth member of the epidermal growth factor receptor family. Proc Natl Acad Sci USA 90:1746?1750, 1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/bjc.1991.100","volume":"63","author":"WJ Gullick","year":"1990","unstructured":"Gullick WJ, Love SB, Wright C, Barnes DM, Gusterson B, Harris AL, Altman DG: c-erbB2 protein over-expression in breast cancer is a risk factor in patients with involved and uninvolved lymph nodes. Br J Cancer 63:434?438, 1990","journal-title":"Br J Cancer"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1146\/annurev.bi.62.070193.002321","volume":"62","author":"WJ Fantl","year":"1993","unstructured":"Fantl WJ, Johnson DE, Williams LT: Signalling by receptor tyrosine kinases. Annu Rev Biochem 62:453?481, 1993","journal-title":"Annu Rev Biochem"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0167-7306(08)60671-7","volume-title":"Hormones and their Actions, Part II","author":"WJ Gullick","year":"1988","unstructured":"Gullick WJ: A comparison of the structure of single polypeptide chain growth factor receptors that possess protein tyrosine kinase activity.In: Cooke BA, King RJB, van der Molen HJ (eds) Hormones and their Actions, Part II. Elsevier, Amsterdam, 1988, pp 349?359"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0955-2235(92)90002-Y","volume":"4","author":"SA Prigent","year":"1992","unstructured":"Prigent SA, Lemoine NR: The type 1(EGFR-related) family of growth factor receptors and their ligands. Prog Growth Factor Res 4:1?24, 1992","journal-title":"Prog Growth Factor Res"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1073\/pnas.90.7.2900","volume":"90","author":"MH Kraus","year":"1993","unstructured":"Kraus MH, Fedi P, Starks V, Muraro R, Aaronson SA: Demonstration of ligand-dependent signalling by the erbB-3 tyrosine kinase and its constitutive activation in human breast tumour cells. Proc Natl Acad Sci USA 90:2900?2904, 1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"CR11","unstructured":"Prigent SA, Gullick WJ: Interaction of an EGF receptor\/c-erbB3 chimera with SH2 signalling pathways. EMBO J, submitted"},{"key":"CR12","first-page":"1398","volume":"i","author":"JRC Sainsbury","year":"1987","unstructured":"Sainsbury JRC, Farndon JR, Needham GK, Malcolm AJ, Harris AL: Epidermal-growth-factor receptor status as predictor of early recurrence of and death from breast cancer. Lancet i:1398?1402, 1987","journal-title":"Lancet"},{"key":"CR13","first-page":"3","volume":"13","author":"JGM Klijn","year":"1992","unstructured":"Klijn JGM, Berns PMJJ, Schmitz PIM, Foekens JA: The clinical significance of epidermal growth factor receptor (EGFR) in human breast cancer: A review on 5232 patients. Endocrine Reviews 13:3?17, 1992","journal-title":"Endocrine Reviews"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/S0959-8049(05)80215-1","volume":"29","author":"RI Nicholson","year":"1993","unstructured":"Nicholson RI, McClelland RA, Finlay P, Eaton CL, Gullick WJ, Dixon AR, Robertson JFR, Ellis IO, Blamey RW: Relationship between EGFR, c-erbB2 protein expression and Ki67 immunostaining in breast cancer and hormone sensitivity. Eur J Cancer 29A:1018?1023, 1993","journal-title":"Eur J Cancer"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/0092-8674(90)90075-P","volume":"61","author":"EP Sandgren","year":"1990","unstructured":"Sandgren EP, Luetteke NC, Palmiter RD, Brinster RL, Lee DC: Overexpression of TGF-alpha in transgenic mice: Induction of epithelial hyperplasia, pancreatic metaplasia, and carcinoma of the breast. Cell 61:1121?1135, 1990","journal-title":"Cell"},{"key":"CR16","first-page":"161","volume-title":"Genes, Oncogenes and Hormones: Advances in Cellular and Molecular Biology of Breast Cancer","author":"FJ Lofts","year":"1992","unstructured":"Lofts FJ, Gullick WJ: c-erbB2 amplification and overexpression in human tumours.In: Dickson RB, Lippman ME (eds) Genes, Oncogenes and Hormones: Advances in Cellular and Molecular Biology of Breast Cancer. Kluwer, Norwell, 1992, pp 161?179"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/bjc.1988.239","volume":"58","author":"BA Gusterson","year":"1988","unstructured":"Gusterson BA, Machin LG, Gullick WJ, Gibbs NM, Powles TJ, Elliot C, Ashley S, Monaghan P, Harrison S: c-erbB-2 expression in benign and malignant disease. Br J Cancer 58:453?457, 1988","journal-title":"Br J Cancer"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/bjc.1991.78","volume":"63","author":"TJ Perren","year":"1991","unstructured":"Perren TJ: c-erbB2 oncogene as a prognostic marker in breast cancer. Br J Cancer 63:328?332, 1991","journal-title":"Br J Cancer"},{"key":"CR19","first-page":"556","volume":"51","author":"MC Paterson","year":"1991","unstructured":"Paterson MC, Dietrich KD, Danyluk J, Paterson AHG, Lees AW, Jamil N, Hanson J, Jenkins H, Krause BE, McBlain WA, Slamon DJ, Fourney RM: Correlation between c-erbB2 amplification and risk of recurrent disease in node-negative breast cancer. Cancer Res 51:556?567, 1991","journal-title":"Cancer Res"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1126\/science.2470152","volume":"244","author":"DJ Slamon","year":"1989","unstructured":"Slamon DJ, Godolphin W, Jones LA, Holt LA, Wong SG, Keith DE, Levin WJ, Stuart SG, Udove J, Ullrich A, Press MF: Studies of the HER2\/neu proto-oncogene in human breast and ovarian cancer. Science 244:707?712, 1989","journal-title":"Science"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1200\/JCO.1989.7.8.1120","volume":"7","author":"AK Tandon","year":"1989","unstructured":"Tandon AK, Clark GM, Chamness GC, Ullrich A, McGuire WL: HER2\/neu oncogene protein and prognosis in breast cancer. J Clin Oncol 7:1120?1128, 1989","journal-title":"J Clin Oncol"},{"key":"CR22","first-page":"1001","volume":"5","author":"C Dati","year":"1990","unstructured":"Dati C, Antoniotti S, Taverna D, Perroteau I, De Bortoli M: Inhibition of c-erbB2 oncogene expression by estrogens in human breast cancer cells. Oncogene 5:1001?1006, 1990","journal-title":"Oncogene"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/BF01961241","volume":"24","author":"CC Benz","year":"1992","unstructured":"Benz CC, Scott GK, Sarup JC, Johnson RM, Tripathy D, Coronando E, Shepard HM, Osborne CK: Estrogen dependent, tamoxifen-resistant tumorigenic growth of MCF-7 cells transfected with HER2\/neu. Breast Cancer Res Treat 24:85?95, 1992","journal-title":"Breast Cancer Res Treat"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/0960-0760(90)90424-J","volume":"37","author":"S Nicholson","year":"1990","unstructured":"Nicholson S, Wright C, Sainsbury JRC, Halcrow P, Kelly P, Angus B, Farndon JR, Harris AL: Epidermal growth factor receptor (EGFr) as a marker for poor prognosis in node-negative breast cancer patients: neu and tamoxifen failure. J Steroid Biochem Molec Biol 37:811?814, 1990","journal-title":"J Steroid Biochem Molec Biol"},{"key":"CR25","first-page":"2087","volume":"49","author":"C Wright","year":"1989","unstructured":"Wright C, Angus B, Nicholson S, Sainsbury JRC, Cairns J, Gullick WJ, Kelly P, Harris AL, Horne CHW: Expression of c-erbB2 oncoprotein: a prognostic indicator in human breast cancer. Cancer Res 49:2087?2090, 1989","journal-title":"Cancer Res"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1002\/j.1460-2075.1987.tb04797.x","volume":"6","author":"MH Kraus","year":"1987","unstructured":"Kraus MH, Popescu NC, Amsbaugh SC, King CR: Overexpression of the EGF receptor-related protooncogene erbB2 in human mammary tumor cell lines by different molecular mechanisms. EMBO J 6:605?610, 1987","journal-title":"EMBO J"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1002\/j.1460-2075.1988.tb02991.x","volume":"7","author":"RC King","year":"1988","unstructured":"King RC, Borrello I, Bellot F, Comoglio P, Schlessinger J: EGF binding to its receptor triggers a rapid tyrosine phosphorylation of the erbB2 protein in the mammary tumor cell line SKBR3. EMBO J 7:1647?1651, 1988","journal-title":"EMBO J"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"11024","DOI":"10.1021\/bi00502a002","volume":"29","author":"R Goldman","year":"1990","unstructured":"Goldman R, Levy RB, Peles E, Yarden Y: Heterodimerisation of the erbB1 and erbB2 receptors in human breast carcinoma cells: A mechanism for receptor transregulation. Biochemistry 29:11024?11028, 1990","journal-title":"Biochemistry"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"4905","DOI":"10.1073\/pnas.87.13.4905","volume":"87","author":"GD Plowman","year":"1990","unstructured":"Plowman GD, Whitney GS, Neubauer MG, Green JM, McDonald VL, Todaro GJ, Shoyab M: Molecular cloning and expression of an additional epidermal growth factor receptor-related gene. Proc Natl Acad Sci USA 87:4905?4909, 1990","journal-title":"Proc Natl Acad Sci USA"},{"key":"CR30","first-page":"1273","volume":"7","author":"SA Prigent","year":"1992","unstructured":"Prigent SA, Lemoine NR, Hughes CM, Plowman GD, Selden C, Gullick WJ: Expression of the c-erbB3 protein in normal human adult and fetal tissues. Oncogene 7:1273?1278, 1992","journal-title":"Oncogene"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/path.1711700309","volume":"170","author":"T Rajkumar","year":"1993","unstructured":"Rajkumar T, Gooden CSR, Lemoine NR, Gullick WJ: Expression of the c-erbB3 protein in gastrointestinal tract tumours determined by monoclonal antibody RTJ1. J Pathol 170:271?278, 1993","journal-title":"J Pathol"},{"key":"CR32","first-page":"3393","volume":"8","author":"A Skinner","year":"1993","unstructured":"Skinner A, Hurst HC: Transcriptional regulation of the c-erbB-3 gene in human breast carcinoma cell lines. Oncogene 8:3393?3401, 1993","journal-title":"Oncogene"},{"key":"CR33","unstructured":"Gasparini G, Gullick WJ, Maluta S, Palma PD, Caffo O, Meli S, Leonardi E, Boracchi P, Pozza F, Lemoine NR, Bevilacqua P: c-erbB3 and c-erbB2 gene expression in node-negative breast carcinoma. Eur J Cancer, in press"},{"key":"CR34","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1006\/bbrc.1993.1542","volume":"192","author":"M Katoh","year":"1993","unstructured":"Katoh M, Yazaki Y, Sugimura T, Terada M: c-erbB3 gene encodes secreted as well as transmembrane receptor tyrosine kinase. Biochem Biophys Res Commun 192:1189?1197, 1993","journal-title":"Biochem Biophys Res Commun"},{"key":"CR35","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1128\/MCB.13.4.2247","volume":"13","author":"GK Scott","year":"1993","unstructured":"Scott GK, Robles R, Park JW, Montgomery PA, Daniel J, Holmes WE, Lee J, Keller GA, Li WL, Fendly BM, Wood WI, Shepard HM, Benz CC: A truncated intracellular HER2\/neu receptor produced by alternative RNA processing affects growth of human carcinoma cells. Mol Cell Biol 13:2247?2257, 1993","journal-title":"Mol Cell Biol"},{"key":"CR36","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1128\/MCB.12.2.883","volume":"12","author":"TW Flickinger","year":"1992","unstructured":"Flickinger TW, Maihle NJ, Kung HJ: An alternatively processed mRNA from the avian c-erbB gene encodes a soluble, truncated form of the receptor that can block ligand-dependent transformation. Mol Cell Biol 12:883?893, 1992","journal-title":"Mol Cell Biol"},{"key":"CR37","doi-asserted-by":"crossref","first-page":"7792","DOI":"10.1073\/pnas.88.17.7792","volume":"88","author":"F Ciardiello","year":"1991","unstructured":"Ciardiello F, Kim N, Saeki T, Dono R, Persico MG, Plowman GD, Garrigues J, Radke S, Todaro GJ, Salomon DS: Differential expression of epidermal growth factor-related proteins in human colorectal tumours. Proc Natl Acad Sci USA 88:7792?7796, 1991","journal-title":"Proc Natl Acad Sci USA"},{"key":"CR38","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/path.1711680306","volume":"168","author":"DN Poller","year":"1992","unstructured":"Poller DN, Spendlove I, Baker C, Church R, Ellis IO, Plowman GD, Mayer RJ: Production and characterisation of a polyclonal antibody to the c-erbB3 protein: Examination of c-erbB3 protein expression in adenocarcinomas. J Pathol 168:275?280, 1992","journal-title":"J Pathol"},{"key":"CR39","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/path.1711680305","volume":"168","author":"NR Lemoine","year":"1992","unstructured":"Lemoine NR, Lobresco M, Leung H, Barton C, Hughes CM, Prigent SA, Gullick WJ, Kloppel G: The erbB3 gene in human pancreatic cancer. J Pathol 168:269?273, 1992","journal-title":"J Pathol"},{"key":"CR40","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1002\/ijc.2910540612","volume":"54","author":"EE Sanidas","year":"1993","unstructured":"Sanidas EE, Filipe MI, Linehan J, Lemoine NR, Gullick WJ, Rajkumar T, Levison DA: Expression of the c-erbB3 gene product in gastric cancer. Int J Cancer 54:935?940, 1993","journal-title":"Int J Cancer"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00666177.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00666177\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00666177","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,5]],"date-time":"2019-04-05T03:33:32Z","timestamp":1554435212000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00666177"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1994]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1994]]}},"alternative-id":["BF00666177"],"URL":"https:\/\/doi.org\/10.1007\/bf00666177","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[1994]]}}}